Evidence map›Paper›PMID 37565930›Full record

ArticleJournal of breast cancer2023

Eric Jonathan Maciel-Cruz, Luis Eduardo Figuera-Villanueva, Asbiel Felipe Garibaldi-Ríos, Belinda Claudia Gómez-Meda, Guillermo Moisés Zúñiga-González, Ana María Pérez, Paola B Castro-García, Ramiro Ramírez-Patiño, Martha Patricia Gallegos-Arreola

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of breast cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eric Jonathan Maciel-CruzDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, México.ORCID https://orcid.org/0000-0001-6820-9001
Luis Eduardo Figuera-VillanuevaDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, México.ORCID https://orcid.org/0000-0002-6096-4579
Asbiel Felipe Garibaldi-RíosDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, México.ORCID https://orcid.org/0009-0003-9788-1106
Belinda Claudia Gómez-MedaDepartamento de Biología Molecular y Genómica, Instituto de Genética Humana "Dr. Enrique Corona Rivera", Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara (UdeG), Guadalajara, México.ORCID https://orcid.org/0000-0003-2774-6390
Guillermo Moisés Zúñiga-GonzálezDivisión de Medicina Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, México.ORCID https://orcid.org/0000-0003-1257-4637
Ana María PérezLaboratorio de Inmunofarmacología, Centro Universitario de Ciencias Exactas e Ingenierías Universidad de Guadalajara (UdeG), Guadalajara, México.ORCID https://orcid.org/0000-0002-7625-7385
Paola B Castro-GarcíaLaboratorio de Inmunofarmacología, Centro Universitario de Ciencias Exactas e Ingenierías Universidad de Guadalajara (UdeG), Guadalajara, México.ORCID https://orcid.org/0000-0002-8905-1837
Ramiro Ramírez-PatiñoDepartamento de Medicina y Ciencias de la Vida, Centro Universitario la Ciénega, Universidad de Guadalajara (UdeG), Ocotlán, México.ORCID https://orcid.org/0009-0001-6275-9034
Martha Patricia Gallegos-ArreolaDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, México. marthapatriciagallegos08@gmail.com.ORCID https://orcid.org/0000-0003-4539-1693
Mexican Social Security Institute · MXUniversidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAssociation between variants rs1047972 and rs8173 of the

methodsGenomic DNA samples from 409 healthy women and 572 patients with BC were analyzed for variants rs1047972 and rs8173 of the

resultsTT genotype (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.22-5.11;

conclusionVariants rs1047972 and rs8173 of the

Indexed as

Aurora Kinase ABreast NeoplasmsDNA Restriction EnzymesGenotypeRisk Factors

Identifiers

PMID37565930
PMCPMC10475707
OpenAlexW4385352990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.